查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1771575

肥胖數位健康市場規模、佔有率和趨勢分析報告：按組件、最終用途、地區和細分市場預測，2025 年至 2033 年

Digital Health For Obesity Market Size, Share & Trends Analysis Report By Component, By End-use, By Region, And Segment Forecasts, 2025 - 2033
出版日期: | 出版商: Grand View Research | 英文 130 Pages | 商品交期: 2-10個工作天內

價格

肥胖數位健康市場的成長與趨勢：

根據Grand View Research, Inc.的最新報告，全球肥胖數位健康市場預計到2033年將達到3928.9億美元，2025年至2033年的複合年成長率為24.0%。

全球肥胖率不斷上升，影響超過19億成年人，這催生了對體重管理解決方案的龐大市場需求。久坐不動和不健康的飲食習慣等生活方式的改變，對這一成長貢獻巨大。人們對肥胖相關健康風險（例如糖尿病和心血管疾病）的認知不斷提高，促使人們尋求有效的干涉措施。此外，技術進步以及數位健康解決方案、個人化飲食建議應用程式和穿戴式裝置的興起，正鼓勵更多人利用科技手段進行體重管理，進一步推動市場成長。健康意識、技術創新以及對有效體重管理解決方案的迫切需求共同推動著市場的成長。

此外，肥胖市場數位健康解決方案的成長歸因於肥胖及相關健康狀況的日益成長以及人們健康意識的不斷增強。人工智慧 (AI) 和機器學習 (ML) 等先進技術的融入預計將進一步促進市場擴張。市場上出現了各種減重應用程式，它們可在 iOS 和 Android 等各種作業系統上運行。這些應用程式涵蓋生活方式監測、食物追蹤、體重管理和運動監測等各個方面。全球肥胖趨勢日益加劇，從而增加了對減重應用程式的需求。

此外，受新冠疫情影響，肥胖數位健康市場對遠距患者管理 (RPM) 的接受度有所提升。便捷易用的工具降低了治療門檻，並消除了經常面對面問診的需要。 RPM 使醫療專業人員能夠持續監測患者並及時提供遠距協助，這對於行動不便和日程繁忙的患者來說非常有利。這種經濟高效且便捷的方法能夠有效管理體重，促進更高的參與度和個人化醫療服務。

市場上的主要企業專注於產品塑造和擴大影響力，採用聯盟、併購、夥伴關係和產品發布等策略。例如，2023 年 10 月，專注於使用人工智慧組織醫療資訊的新興企業Mendel.ai 推出了人工智慧平台 Hypercube。該創新系統整合了結構化和非結構化文字數據，使分析民主化，並允許使用者以自由文本形式提出問題。然後，Hypercube 提供來自特定患者數據的結果，使醫療資訊分析更易於存取和高效。 2023 年 5 月，Noom, Inc. 推出了 Noom Med，旨在對抗肥胖這種疾病。 Noom Med 將一系列遠距遠端醫療服務與 Noom 的個人化心理工具相結合，以促進永續減重。該計劃是該公司廣泛使用的消費者解決方案 Noom Weight 的延伸，它利用心理學原理、人工協助和技術來幫助患者克服永續減重的障礙。

肥胖數位健康市場報告重點

  • 按組成部分分類，服務部門在 2024 年佔據了最大的市場收益佔有率。這種成長歸因於對安裝、維護、培訓和其他服務的需求不斷成長。
  • 根據最終用途，預計患者部分將在 2024 年佔據最大的市場佔有率，並在預測期內以最快的複合年成長率成長。
  • 2024 年，北美佔據市場主導地位，收益佔有率超過 37.7%。這是由於醫療保健 IT 支出的增加、適當的數位基礎設施的可用性、技術進步以及新興企業的興起。

目錄

第1章調查方法與範圍

第2章執行摘要

3. 肥胖數位健康市場變數、趨勢與範圍

  • 市場體系展望
    • 母市場展望
    • 相關/輔助市場展望
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
  • 肥胖數位健康市場分析工具
    • 產業分析-波特五力分析
    • PESTEL分析
  • 市場新技術趨勢
  • 市場技術格局
  • 案例研究分析
  • 特定國家的法規和報銷情況
  • 價值鏈分析
  • 市場資金籌措/投資場景
    • 創業投資（VC）交易活動
    • 2024年十大數位健康創投交易
    • 年度股權資金籌措和交易
    • 季度股權資金籌措和交易
    • 全球各地區季度資金籌措及交易狀況
    • 全球各地區季度交易佔比
    • 按投資者群體分類的季度交易明細
    • 年度平均和中位數交易規模
    • 全球各地區平均年度交易規模
    • 投資者群體的年度平均交易規模
    • 年度大型資金籌措和交易
    • 季度資金籌措和巨額融資交易
    • 全球各地區季度巨額資金籌措及交易狀況
    • 全球各地區季度巨額融資交易情況
    • 每季巨額融資資金籌措
    • 季度股票交易
    • 各交易階段的年度交易率
    • 各季度區域交易佔有率（依交易階段分類）
    • 各交易階段的年平均資金籌措額
    • 季度種子/天使交易
    • 季度 A 輪交易
    • 季度 B 輪交易
    • 季度 C 輪交易
    • 季度 D 輪交易
    • 季度 E+ 系列交易
  • 數位健康獨角獸公司的資金籌措趨勢
    • 每季新增獨角獸數量和總合
    • 季度新獨角獸公司（按地區分類）及全球公司總合
    • 全球各地區每季新獨角獸數量
    • 季度獨角獸估值
  • 數位醫療市場的退出趨勢
    • 年度退休福利
    • 季度退出趨勢
    • 全球各地區季度離職率
    • 季度併購退出趨勢
    • 季度IPO
  • 數位健康領域主要投資者分析
    • 按每季公司數量分類的投資者
    • 每季創投公司數量
    • 企業創投（CVC）以每季公司數量分類
  • 數位健康市場的主要區域投資趨勢
    • 美國趨勢
    • 亞洲趨勢
    • 中國
    • 日本
    • 歐洲趨勢
    • 英國

第4章肥胖數位健康市場：各組成部分的估計和趨勢分析

  • 定義和範圍
  • 2024 年及 2033 年各組件市場佔有率
  • 細分儀表板
  • 肥胖數位健康市場：各組成部分的展望
  • 軟體
  • 硬體
  • 服務

第5章肥胖數位健康市場：按最終用途的估計和趨勢分析

  • 定義和範圍
  • 2024 年和 2033 年按最終用途分類的市場佔有率
  • 細分儀表板
  • 肥胖數位健康市場：按最終用途分類的展望
  • 病人
  • 醫療保健專業人員
  • 醫療保健付款人
  • 其他

第6章肥胖數位健康市場：按地區估計和趨勢分析

  • 2024 年及 2033 年各地區市場佔有率分析
  • 區域市場儀表板
  • 全球區域市場概況
  • 按地區進行的 SWOT 分析
  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 挪威
    • 瑞典
    • 丹麥
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 韓國
    • 新加坡
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第7章 競爭態勢

  • 主要市場參與企業的近期趨勢和影響分析
  • 公司/競爭對手分類
    • 創新者
  • 2024年主要企業市場分析
  • List of Companies
    • WW International
    • MyFitnessPal Inc.
    • Teladoc
    • FitnessKeeper
    • Healthify (My Diet Coach)
    • PlateJoy
    • Tempus
    • Fitbit, Inc.
    • Noom
    • WellDoc
    • Sidekick Health
    • BioAge Labs
Product Code: GVR-4-68040-255-7

Digital Health For Obesity Market Growth & Trends:

The global digital health for obesity market size is estimated to reach USD 392.89 billion by 2033, registering a CAGR of 24.0% from 2025 to 2033, according to a new report by Grand View Research, Inc. Rising global obesity rates, with over 1.9 billion adults affected, have created a substantial market demand for weight management solutions. Lifestyle changes, including sedentary habits and unhealthy dietary choices, contribute significantly to this growth. The increasing awareness of obesity-related health risks, such as diabetes and cardiovascular diseases, propels individuals toward seeking effective interventions. In addition, advancements in technology and the emergence of digital health solutions, personalized dietary guidance apps, and wearable devices, further drive market growth as people increasingly turn to technology for managing their weight. The intersection of health consciousness, technological innovation, and the urgent need for effective weight management solutions collectively fuels the market growth.

Furthermore, the growth of digital health solutions in obesity market can be attributed to a rising prevalence of obesity and associated health conditions, alongside growing health awareness. Incorporating advanced technologies such as artificial intelligence (AI) and machine learning (ML) is anticipated to further contribute to market expansion. Various weight loss apps are being launched in that market that offer applications on various operating systems, including iOS, Android, and others. These apps cater to various aspects such as lifestyle monitoring, diet tracking, weight management, exercise monitoring, and more. As obesity rates continue to rise globally, there is an increasing demand for weight loss apps, and companies are leveraging this trend to their advantage.

Furthermore, the digital health obesity market has witnessed increased acceptance of remote patient management (RPM) due to the impact of the COVID-19 pandemic. Implementing convenient and accessible tools has diminished obstacles to care, eliminating the necessity for frequent in-person visits. RPM allows healthcare professionals to consistently monitor patients and provide timely remote assistance, proving advantageous for individuals with limited mobility or hectic schedules. This cost-effective and convenient approach enables effective weight management and promotes heightened engagement and personalized healthcare.

The major players operating in the market are adopting strategies such as collaborations, mergers and acquisitions, and partnerships, product launches, with a major focus on enhancing product formation and reach. For instance, in October 2023, Mendel.ai, a startup specializing in the utilization of artificial intelligence for organizing medical information, unveiled Hypercube, an AI-powered platform. This innovative system integrates both structured and unstructured text data, democratizing analytics and enabling users to pose questions in free text. Hypercube then provides outcomes derived from specific patient data, enhancing accessibility and efficiency in medical information analysis. In May 2023, Noom, Inc. introduced Noom Med, designed to combat obesity as a disease. Noom Med integrates a range of telehealth services with Noom's personalized psychological tools to facilitate enduring weight loss. This program, an augmentation of Noom Weight, the company's widely used consumer-facing solution, utilizes psychological principles, human assistance, and technology to empower patients in overcoming obstacles to sustained weight loss.

Digital Health For Obesity Market Report Highlights:

  • Based on component, the services segment accounted for the largest market revenue share in 2024. This growth can be attributed to the growing demand for installation, maintenance, training, and other services.
  • Based on end-use, the patient segment accounted with the largest market share in 2024 and is anticipated to witness at the fastest CAGR over the forecast period.
  • North America dominated the market in 2024 with a revenue share of over 37.7%, owing to growing healthcare IT expenditure, availability of adequate digital infrastructure, technological advancements, the emergence of startups.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Component
    • 1.1.2. End Use
    • 1.1.3. Regional scope
    • 1.1.4. Estimates and forecast timeline.
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database.
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
  • 1.4. Information or Data Analysis
    • 1.4.1. Data analysis models
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
    • 1.6.1. Commodity flow analysis (Model 1)
    • 1.6.2. Approach 1: Commodity flow approach
    • 1.6.3. Volume price analysis (Model 2)
    • 1.6.4. Approach 2: Volume price analysis
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Component outlook
    • 2.2.2. End Use outlook.
    • 2.2.3. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Digital Health for Obesity Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook.
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Growing adoption of digital technology in obesity care
      • 3.2.1.2. Increasing use of artificial intelligence (AI), internet of things (IoT), and big data
      • 3.2.1.3. Growing adoption of mobile health applications and technologies
      • 3.2.1.4. Increasing burden of mental disorders
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. Privacy and security concerns
      • 3.2.2.2. Lack of healthcare infrastructure
  • 3.3. Digital Health for Obesity Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape
  • 3.4. Emerging Technological Trends in the Market
  • 3.5. Technology Landscape in the Market
  • 3.6. Case Study Analysis
  • 3.7. Regulatory and Reimbursement Scenario, by Country
  • 3.8. Value Chain Analysis
  • 3.9. Market Funding/Investment Scenario
    • 3.9.1. Venture capital (VC) deal activity
    • 3.9.2. Top 10 digital health VC deals in 2024
    • 3.9.3. Annual equity funding & deals
    • 3.9.4. Quarterly equity funding & deals
    • 3.9.5. Quarter funding & deals by global region
    • 3.9.6. Percent of quarterly deals by global region
    • 3.9.7. Percent of quarterly deals by investor group
    • 3.9.8. Annual average & median deal size
    • 3.9.9. Annual median deal size by global region
    • 3.9.10. Annual median deal size by investor group
    • 3.9.11. Annual mega-round funding & deals
    • 3.9.12. Quarterly funding & deals from mega-rounds (deals worth usd 100 million+)
    • 3.9.13. Quarter mega-round funding & deals by global region
    • 3.9.14. Quarterly mega-round deals by global region
    • 3.9.15. Quarterly mega-rounds as percentage of funding
    • 3.9.16. Quarter top equity deals
    • 3.9.17. Annual percentage of deals by deal stage
    • 3.9.18. Quarter regional deal shares by deal stage
    • 3.9.19. Annual median funding by deal stage
    • 3.9.20. Quarter top seed/angel deals
    • 3.9.21. Quarter top series A deals
    • 3.9.22. Quarter top series B deals
    • 3.9.23. Quarter top series C deals
    • 3.9.24. Quarter top series D deals
    • 3.9.25. Quarter top series E+ deals
  • 3.10. Unicorn Funding Trends in Digital Health
    • 3.10.1. Quarterly new & total unicorns (private companies valued at USD 1 billion+)
    • 3.10.2. Quarter new & total unicorns by global region
    • 3.10.3. Quarterly new unicorns by global region
    • 3.10.4. Quarter top unicorns by valuation
  • 3.11. Exit Trends in Digital Health Market
    • 3.11.1. Annual exits
    • 3.11.2. Quarterly exits
    • 3.11.3. Percent of quarterly exits by global region
    • 3.11.4. Quarter top M&A exits
    • 3.11.5. Quarter top IPOs
  • 3.12. Key Investors Analysis in the Digital Health Landscape
    • 3.12.1. Quarter top investors by company count
    • 3.12.2. Quarter top VCs by company count
    • 3.12.3. Quarter top corporate VCs (CVCs) by company count
  • 3.13. Key Investment Geographic Trends in Digital Health Market
    • 3.13.1. U.S. Trends
      • 3.13.1.1. Annual funding & deals
      • 3.13.1.2. Quarterly funding & deals
      • 3.13.1.3. Annual percentage of deals by deal stage
      • 3.13.1.4. Quarter top equity deals
      • 3.13.1.5. Annual exits
      • 3.13.1.6. Quarterly exists
      • 3.13.1.7. Quarter top investors by company count
    • 3.13.2. Asia Trends
      • 3.13.2.1. Annual funding & deals
      • 3.13.2.2. Quarterly funding & deals
      • 3.13.2.3. Annual percentage of deals by deal stage
      • 3.13.2.4. Quarter top equity deals
      • 3.13.2.5. Annual exits
      • 3.13.2.6. Quarterly exists
      • 3.13.2.7. Quarter top investors by company count
    • 3.13.3. China
    • 3.13.4. Japan
    • 3.13.5. Europe Trends
      • 3.13.5.1. Annual funding & deals
      • 3.13.5.2. Quarterly funding & deals
      • 3.13.5.3. Annual percentage of deals by deal stage
      • 3.13.5.4. Quarter top equity deals
      • 3.13.5.5. Annual exits
      • 3.13.5.6. Quarterly exists
      • 3.13.5.7. Quarter top investors by company count
    • 3.13.6. UK

Chapter 4. Digital Health for Obesity Market: Component Estimates & Trend Analysis

  • 4.1. Definition and Scope
  • 4.2. Component Market Share, 2024 & 2033
  • 4.3. Segment Dashboard
  • 4.4. Global Digital Health for Obesity Market by Component Outlook
  • 4.5. Software
    • 4.5.1. Market estimates and forecast 2021 to 2033 (USD Million)
  • 4.6. Hardware
    • 4.6.1. Market estimates and forecast 2021 to 2033 (USD Million)
  • 4.7. Services
    • 4.7.1. Market estimates and forecast 2021 to 2033 (USD Million)

Chapter 5. Digital Health for Obesity Market: End Use Estimates & Trend Analysis

  • 5.1. Definition and Scope
  • 5.2. End Use Market Share, 2024 & 2033
  • 5.3. Segment Dashboard
  • 5.4. Global Digital Health for Obesity Market by End Use Outlook
  • 5.5. Patients
    • 5.5.1. Market estimates and forecast 2021 to 2033 (USD Million)
  • 5.6. Providers
    • 5.6.1. Market estimates and forecast 2021 to 2033 (USD Million)
  • 5.7. Payers
    • 5.7.1. Market estimates and forecast 2021 to 2033 (USD Million)
  • 5.8. Others
    • 5.8.1. Market estimates and forecast 2021 to 2033 (USD Million)

Chapter 6. Digital Health for Obesity Market: Regional Estimates & Trend Analysis, By Component, By End Use

  • 6.1. Regional Market Share Analysis, 2024 & 2033
  • 6.2. Regional Market Dashboard
  • 6.3. Global Regional Market Snapshot
  • 6.4. SWOT Analysis, by Region
  • 6.5. North America
    • 6.5.1. U.S.
      • 6.5.1.1. Key country dynamics
      • 6.5.1.2. Regulatory framework
      • 6.5.1.3. Competitive scenario
      • 6.5.1.4. U.S. market estimates and forecasts 2021 to 2033 (USD Million)
    • 6.5.2. Canada
      • 6.5.2.1. Key country dynamics
      • 6.5.2.2. Regulatory framework
      • 6.5.2.3. Competitive scenario
      • 6.5.2.4. Canada market estimates and forecasts 2021 to 2033 (USD Million)
  • 6.6. Europe
    • 6.6.1. UK
      • 6.6.1.1. Key country dynamics
      • 6.6.1.2. Regulatory framework
      • 6.6.1.3. Competitive scenario
      • 6.6.1.4. UK market estimates and forecasts 2021 to 2033 (USD Million)
    • 6.6.2. Germany
      • 6.6.2.1. Key country dynamics
      • 6.6.2.2. Regulatory framework
      • 6.6.2.3. Competitive scenario
      • 6.6.2.4. Germany market estimates and forecasts 2021 to 2033 (USD Million)
    • 6.6.3. France
      • 6.6.3.1. Key country dynamics
      • 6.6.3.2. Regulatory framework
      • 6.6.3.3. Competitive scenario
      • 6.6.3.4. France market estimates and forecasts 2021 to 2033 (USD Million)
    • 6.6.4. Italy
      • 6.6.4.1. Key country dynamics
      • 6.6.4.2. Regulatory framework
      • 6.6.4.3. Competitive scenario
      • 6.6.4.4. Italy market estimates and forecasts 2021 to 2033 (USD Million)
    • 6.6.5. Spain
      • 6.6.5.1. Key country dynamics
      • 6.6.5.2. Regulatory framework
      • 6.6.5.3. Competitive scenario
      • 6.6.5.4. Spain market estimates and forecasts 2021 to 2033 (USD Million)
    • 6.6.6. Norway
      • 6.6.6.1. Key country dynamics
      • 6.6.6.2. Regulatory framework
      • 6.6.6.3. Competitive scenario
      • 6.6.6.4. Norway market estimates and forecasts 2021 to 2033 (USD Million)
    • 6.6.7. Sweden
      • 6.6.7.1. Key country dynamics
      • 6.6.7.2. Regulatory framework
      • 6.6.7.3. Competitive scenario
      • 6.6.7.4. Sweden market estimates and forecasts 2021 to 2033 (USD Million)
    • 6.6.8. Denmark
      • 6.6.8.1. Key country dynamics
      • 6.6.8.2. Regulatory framework
      • 6.6.8.3. Competitive scenario
      • 6.6.8.4. Denmark market estimates and forecasts 2021 to 2033 (USD Million)
  • 6.7. Asia Pacific
    • 6.7.1. Japan
      • 6.7.1.1. Key country dynamics
      • 6.7.1.2. Regulatory framework
      • 6.7.1.3. Competitive scenario
      • 6.7.1.4. Japan market estimates and forecasts 2021 to 2033 (USD Million)
    • 6.7.2. China
      • 6.7.2.1. Key country dynamics
      • 6.7.2.2. Regulatory framework
      • 6.7.2.3. Competitive scenario
      • 6.7.2.4. China market estimates and forecasts 2021 to 2033 (USD Million)
    • 6.7.3. India
      • 6.7.3.1. Key country dynamics
      • 6.7.3.2. Regulatory framework
      • 6.7.3.3. Competitive scenario
      • 6.7.3.4. India market estimates and forecasts 2021 to 2033 (USD Million)
    • 6.7.4. Australia
      • 6.7.4.1. Key country dynamics
      • 6.7.4.2. Regulatory framework
      • 6.7.4.3. Competitive scenario
      • 6.7.4.4. Australia market estimates and forecasts 2021 to 2033 (USD Million)
    • 6.7.5. South Korea
      • 6.7.5.1. Key country dynamics
      • 6.7.5.2. Regulatory framework
      • 6.7.5.3. Competitive scenario
      • 6.7.5.4. South Korea market estimates and forecasts 2021 to 2033 (USD Million)
    • 6.7.6. Singapore
      • 6.7.6.1. Key country dynamics
      • 6.7.6.2. Regulatory framework
      • 6.7.6.3. Competitive scenario
      • 6.7.6.4. Singapore market estimates and forecasts 2021 to 2033 (USD Million)
  • 6.8. Latin America
    • 6.8.1. Brazil
      • 6.8.1.1. Key country dynamics
      • 6.8.1.2. Regulatory framework
      • 6.8.1.3. Competitive scenario
      • 6.8.1.4. Brazil market estimates and forecasts 2021 to 2033 (USD Million)
    • 6.8.2. Mexico
      • 6.8.2.1. Key country dynamics
      • 6.8.2.2. Regulatory framework
      • 6.8.2.3. Competitive scenario
      • 6.8.2.4. Mexico market estimates and forecasts 2021 to 2033 (USD Million)
    • 6.8.3. Argentina
      • 6.8.3.1. Key country dynamics
      • 6.8.3.2. Regulatory framework
      • 6.8.3.3. Competitive scenario
      • 6.8.3.4. Argentina market estimates and forecasts 2021 to 2033 (USD Million)
  • 6.9. MEA
    • 6.9.1. South Africa
      • 6.9.1.1. Key country dynamics
      • 6.9.1.2. Regulatory framework
      • 6.9.1.3. Competitive scenario
      • 6.9.1.4. South Africa market estimates and forecasts 2021 to 2033 (USD Million)
    • 6.9.2. Saudi Arabia
      • 6.9.2.1. Key country dynamics
      • 6.9.2.2. Regulatory framework
      • 6.9.2.3. Competitive scenario
      • 6.9.2.4. Saudi Arabia market estimates and forecasts 2021 to 2033 (USD Million)
    • 6.9.3. UAE
      • 6.9.3.1. Key country dynamics
      • 6.9.3.2. Regulatory framework
      • 6.9.3.3. Competitive scenario
      • 6.9.3.4. UAE market estimates and forecasts 2021 to 2033 (USD Million)
    • 6.9.4. Kuwait
      • 6.9.4.1. Key country dynamics
      • 6.9.4.2. Regulatory framework
      • 6.9.4.3. Competitive scenario
      • 6.9.4.4. Kuwait market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 7.2. Company/Competition Categorization
    • 7.2.1. Innovators
  • 7.3. Key company market position analysis, 2024
  • 7.4. List of Companies
    • 7.4.1. WW International
      • 7.4.1.1. Company overview
      • 7.4.1.2. Financial performance
      • 7.4.1.3. Product benchmarking
      • 7.4.1.4. Strategic initiatives
    • 7.4.2. MyFitnessPal Inc.
      • 7.4.2.1. Company overview
      • 7.4.2.2. Financial performance
      • 7.4.2.3. Product benchmarking
      • 7.4.2.4. Strategic initiatives
    • 7.4.3. Teladoc
      • 7.4.3.1. Company overview
      • 7.4.3.2. Financial performance
      • 7.4.3.3. Product benchmarking
      • 7.4.3.4. Strategic initiatives
    • 7.4.4. FitnessKeeper
      • 7.4.4.1. Company overview
      • 7.4.4.2. Financial performance
      • 7.4.4.3. Product benchmarking
      • 7.4.4.4. Strategic initiatives
    • 7.4.5. Healthify (My Diet Coach)
      • 7.4.5.1. Company overview
      • 7.4.5.2. Financial performance
      • 7.4.5.3. Product benchmarking
      • 7.4.5.4. Strategic initiatives
    • 7.4.6. PlateJoy
      • 7.4.6.1. Company overview
      • 7.4.6.2. Financial performance
      • 7.4.6.3. Product benchmarking
      • 7.4.6.4. Strategic initiatives
    • 7.4.7. Tempus
      • 7.4.7.1. Company overview
      • 7.4.7.2. Financial performance
      • 7.4.7.3. Product benchmarking
      • 7.4.7.4. Strategic initiatives
    • 7.4.8. Fitbit, Inc.
      • 7.4.8.1. Company overview
      • 7.4.8.2. Financial performance
      • 7.4.8.3. Product benchmarking
      • 7.4.8.4. Strategic initiatives
    • 7.4.9. Noom
      • 7.4.9.1. Company overview
      • 7.4.9.2. Financial performance
      • 7.4.9.3. Product benchmarking
      • 7.4.9.4. Strategic initiatives
    • 7.4.10. WellDoc
      • 7.4.10.1. Company overview
      • 7.4.10.2. Financial performance
      • 7.4.10.3. Product benchmarking
      • 7.4.10.4. Strategic initiatives
    • 7.4.11. Sidekick Health
      • 7.4.11.1. Company overview
      • 7.4.11.2. Financial performance
      • 7.4.11.3. Product benchmarking
      • 7.4.11.4. Strategic initiatives
    • 7.4.12. BioAge Labs
      • 7.4.12.1. Company overview
      • 7.4.12.2. Financial performance
      • 7.4.12.3. Product benchmarking
      • 7.4.12.4. Strategic initiatives

List of Tables

  • Table 1 List of abbreviation
  • Table 2 North America digital health for obesity market, by region, 2021 - 2033 (USD Million)
  • Table 3 North America digital health for obesity market, by component, 2021 - 2033 (USD Million)
  • Table 4 North America digital health for obesity market, by end use, 2021 - 2033 (USD Million)
  • Table 5 U.S. digital health for obesity market, by component, 2021 - 2033 (USD Million)
  • Table 6 U.S. digital health for obesity market, by end use, 2021 - 2033 (USD Million)
  • Table 7 Canada digital health for obesity market, by component, 2021 - 2033 (USD Million)
  • Table 8 Canada digital health for obesity market, by end use, 2021 - 2033 (USD Million)
  • Table 9 Europe digital health for obesity market, by region, 2021 - 2033 (USD Million)
  • Table 10 Europe digital health for obesity market, by component, 2021 - 2033 (USD Million)
  • Table 11 Europe digital health for obesity market, by end use, 2021 - 2033 (USD Million)
  • Table 12 Germany digital health for obesity market, by component, 2021 - 2033 (USD Million)
  • Table 13 Germany digital health for obesity market, by end use, 2021 - 2033 (USD Million)
  • Table 14 UK digital health for obesity market, by component, 2021 - 2033 (USD Million)
  • Table 15 UK digital health for obesity market, by end use, 2021 - 2033 (USD Million)
  • Table 16 France digital health for obesity market, by component, 2021 - 2033 (USD Million)
  • Table 17 France digital health for obesity market, by end use, 2021 - 2033 (USD Million)
  • Table 18 Italy digital health for obesity market, by component, 2021 - 2033 (USD Million)
  • Table 19 Italy digital health for obesity market, by end use, 2021 - 2033 (USD Million)
  • Table 20 Spain digital health for obesity market, by component, 2021 - 2033 (USD Million)
  • Table 21 Spain digital health for obesity market, by end use, 2021 - 2033 (USD Million)
  • Table 22 Denmark digital health for obesity market, by component, 2021 - 2033 (USD Million)
  • Table 23 Denmark digital health for obesity market, by end use, 2021 - 2033 (USD Million)
  • Table 24 Sweden digital health for obesity market, by component, 2021 - 2033 (USD Million)
  • Table 25 Sweden digital health for obesity market, by end use, 2021 - 2033 (USD Million)
  • Table 26 Norway digital health for obesity market, by component, 2021 - 2033 (USD Million)
  • Table 27 Norway digital health for obesity market, by end use, 2021 - 2033 (USD Million)
  • Table 28 Asia Pacific digital health for obesity market, by region, 2021 - 2033 (USD Million)
  • Table 29 Asia Pacific digital health for obesity market, by component, 2021 - 2033 (USD Million)
  • Table 30 Asia Pacific digital health for obesity market, by end use, 2021 - 2033 (USD Million)
  • Table 31 China digital health for obesity market, by component, 2021 - 2033 (USD Million)
  • Table 32 China digital health for obesity market, by end use, 2021 - 2033 (USD Million)
  • Table 33 Japan digital health for obesity market, by component, 2021 - 2033 (USD Million)
  • Table 34 Japan digital health for obesity market, by end use, 2021 - 2033 (USD Million)
  • Table 35 India digital health for obesity market, by component, 2021 - 2033 (USD Million)
  • Table 36 India digital health for obesity market, by end use, 2021 - 2033 (USD Million)
  • Table 37 South Korea digital health for obesity market, by component, 2021 - 2033 (USD Million)
  • Table 38 South Korea digital health for obesity market, by end use, 2021 - 2033 (USD Million)
  • Table 39 Australia digital health for obesity market, by component, 2021 - 2033 (USD Million)
  • Table 40 Australia digital health for obesity market, by end use, 2021 - 2033 (USD Million)
  • Table 41 Singapore digital health for obesity market, by component, 2021 - 2033 (USD Million)
  • Table 42 Singapore digital health for obesity market, by end use, 2021 - 2033 (USD Million)
  • Table 43 Latin America digital health for obesity market, by region, 2021 - 2033 (USD Million)
  • Table 44 Latin America digital health for obesity market, by component, 2021 - 2033 (USD Million)
  • Table 45 Latin America digital health for obesity market, by end use, 2021 - 2033 (USD Million)
  • Table 46 Brazil digital health for obesity market, by component, 2021 - 2033 (USD Million)
  • Table 47 Brazil digital health for obesity market, by end use, 2021 - 2033 (USD Million)
  • Table 48 Mexico digital health for obesity market, by component, 2021 - 2033 (USD Million)
  • Table 49 Mexico digital health for obesity market, by end use, 2021 - 2033 (USD Million)
  • Table 50 Argentina digital health for obesity market, by component, 2021 - 2033 (USD Million)
  • Table 51 Argentina digital health for obesity market, by end use, 2021 - 2033 (USD Million)
  • Table 52 MEA digital health for obesity market, by region, 2021 - 2033 (USD Million)
  • Table 53 MEA digital health for obesity market, by component, 2021 - 2033 (USD Million)
  • Table 54 MEA digital health for obesity market, by end use, 2021 - 2033 (USD Million)
  • Table 55 South Africa digital health for obesity market, by component, 2021 - 2033 (USD Million)
  • Table 56 South Africa digital health for obesity market, by end use, 2021 - 2033 (USD Million)
  • Table 57 Saudi Arabia digital health for obesity market, by component, 2021 - 2033 (USD Million)
  • Table 58 Saudi Arabia digital health for obesity market, by end use, 2021 - 2033 (USD Million)
  • Table 59 UAE digital health for obesity market, by component, 2021 - 2033 (USD Million)
  • Table 60 UAE digital health for obesity market, by end use, 2021 - 2033 (USD Million)
  • Table 61 Kuwait digital health for obesity market, by component, 2021 - 2033 (USD Million)
  • Table 62 Kuwait digital health for obesity market, by end use, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value-chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 Digital health for obesity market: market outlook
  • Fig. 9 Digital health for obesity competitive insights
  • Fig. 10 Parent market outlook
  • Fig. 11 Related/ancillary market outlook
  • Fig. 12 Digital health for obesity market driver impact
  • Fig. 13 Digital health for obesity market restraint impact
  • Fig. 14 Digital health for obesity market: Component movement analysis
  • Fig. 15 Digital health for obesity market: Component outlook and key takeaways
  • Fig. 16 Software market estimates and forecast, 2021 - 2033
  • Fig. 17 Hardware market estimates and forecast, 2021 - 2033
  • Fig. 18 Services market estimates and forecast, 2021 - 2033
  • Fig. 19 Digital health for obesity market: End use movement analysis
  • Fig. 20 Digital health for obesity market: End use outlook and key takeaways
  • Fig. 21 Patients market estimates and forecast, 2021 - 2033
  • Fig. 22 Providers market estimates and forecast, 2021 - 2033
  • Fig. 23 Payers market estimates and forecast, 2021 - 2033
  • Fig. 24 Others market estimates and forecast, 2021 - 2033
  • Fig. 25 Global digital health for obesity market: Regional movement analysis
  • Fig. 26 Global digital health for obesity market: Regional outlook and key takeaways
  • Fig. 27 Global digital health for obesity market share and leading players
  • Fig. 28 North America: SWOT
  • Fig. 29 Europe SWOT
  • Fig. 30 Asia Pacific SWOT
  • Fig. 31 Latin America SWOT
  • Fig. 32 MEA SWOT
  • Fig. 33 North America, by country
  • Fig. 34 North America
  • Fig. 35 North America market estimates and forecasts, 2021 - 2033
  • Fig. 36 U.S.
  • Fig. 37 U.S. market estimates and forecasts, 2021 - 2033
  • Fig. 38 Canada
  • Fig. 39 Canada market estimates and forecasts, 2021 - 2033
  • Fig. 40 Europe, by country
  • Fig. 41 Europe
  • Fig. 42 Europe market estimates and forecasts, 2021 - 2033
  • Fig. 43 UK
  • Fig. 44 UK market estimates and forecasts, 2021 - 2033
  • Fig. 45 Germany
  • Fig. 46 Germany market estimates and forecasts, 2021 - 2033
  • Fig. 47 France
  • Fig. 48 France market estimates and forecasts, 2021 - 2033
  • Fig. 49 Italy
  • Fig. 50 Italy market estimates and forecasts, 2021 - 2033
  • Fig. 51 Spain
  • Fig. 52 Spain market estimates and forecasts, 2021 - 2033
  • Fig. 53 Denmark
  • Fig. 54 Denmark market estimates and forecasts, 2021 - 2033
  • Fig. 55 Sweden
  • Fig. 56 Sweden market estimates and forecasts, 2021 - 2033
  • Fig. 57 Norway
  • Fig. 58 Norway market estimates and forecasts, 2021 - 2033
  • Fig. 59 Asia Pacific, by country
  • Fig. 60 Asia Pacific
  • Fig. 61 Asia Pacific market estimates and forecasts, 2021 - 2033
  • Fig. 62 China
  • Fig. 63 China market estimates and forecasts, 2021 - 2033
  • Fig. 64 Japan
  • Fig. 65 Japan market estimates and forecasts, 2021 - 2033
  • Fig. 66 India
  • Fig. 67 India market estimates and forecasts, 2021 - 2033
  • Fig. 68 Singapore
  • Fig. 69 Singapore market estimates and forecasts, 2021 - 2033
  • Fig. 70 South Korea
  • Fig. 71 South Korea market estimates and forecasts, 2021 - 2033
  • Fig. 72 Australia
  • Fig. 73 Australia market estimates and forecasts, 2021 - 2033
  • Fig. 74 Latin America, by country
  • Fig. 75 Latin America
  • Fig. 76 Latin America market estimates and forecasts, 2021 - 2033
  • Fig. 77 Brazil
  • Fig. 78 Brazil market estimates and forecasts, 2021 - 2033
  • Fig. 79 Mexico
  • Fig. 80 Mexico market estimates and forecasts, 2021 - 2033
  • Fig. 81 Argentina
  • Fig. 82 Argentina market estimates and forecasts, 2021 - 2033
  • Fig. 83 Middle East and Africa, by country
  • Fig. 84 Middle East and Africa
  • Fig. 85 Middle East and Africa market estimates and forecasts, 2021 - 2033
  • Fig. 86 South Africa
  • Fig. 87 South Africa market estimates and forecasts, 2021 - 2033
  • Fig. 88 Saudi Arabia
  • Fig. 89 Saudi Arabia market estimates and forecasts, 2021 - 2033
  • Fig. 90 UAE
  • Fig. 91 UAE market estimates and forecasts, 2021 - 2033
  • Fig. 92 Kuwait
  • Fig. 93 Kuwait market estimates and forecasts, 2021 - 2033